Rafferty Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Sell |
|
|||||
|
2025
Q1 | $1.4M | Sell |
|
|||||
|
2024
Q4 | $4.1M | Sell |
|
|||||
|
2024
Q3 | $6.13M | Sell |
|
|||||
|
2024
Q2 | $5.81M | Buy |
|
|||||
|
2024
Q1 | $8.66M | Sell |
|
|||||
|
2023
Q4 | $10.1M | Sell |
|
|||||
|
2023
Q3 | $6.81M | Buy |
|
|||||
|
2023
Q2 | $7.41M | Sell |
|
|||||
|
2023
Q1 | $6.69M | Sell |
|
|||||
|
2022
Q4 | $7.45M | Buy |
|
|||||
|
2022
Q3 | $5.93M | Buy |
|
|||||
|
2022
Q2 | $5.08M | Buy |
|
|||||
|
2022
Q1 | $6.75M | Buy |
|
|||||
|
2021
Q4 | $5.45M | Buy |
|
|||||
|
2021
Q3 | $3.38M | Buy |
|
|||||
|
2021
Q2 | $2.89M | Buy |
|
|||||
|
2021
Q1 | $3.04M | Buy |
|
|||||
|
2020
Q4 | $866K | Sell |
|
|||||
|
2020
Q3 | $2.06M | Buy |
|
|||||
|
2020
Q2 | $888K | Buy |
|
|||||
|
2020
Q1 | $363K | Sell |
|
|||||
|
2019
Q4 | $2.85M | Sell |
|
|||||
|
2019
Q3 | $4.4M | Buy |
|
|||||
|
2019
Q2 | $2.36M | Sell |
|
|||||
|
2019
Q1 | $1.41M | Buy |
|